Ms. Natalie Swoveland, LCMHC ASSOCIATE Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 617 N Main St, Troy, NC 27371 Phone: 910-384-1581 |
Mrs. Lisa Anne Atkins, LCSW LCAS Counselor Medicare: Accepting Medicare Assignments Practice Location: 318 North Main Street, Troy, NC 27371 Phone: 910-576-1188 Fax: 910-576-1182 |
Mrs. Tyler Leigh-ann Talbert, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 227 N Main St, Troy, NC 27371 Phone: 970-572-3681 |
Mrs. Vanna Niccole Lee, LPCA Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 617 N Main St, Troy, NC 27371 Phone: 910-572-2225 Fax: 910-571-0234 |
Mrs. Dana Bandy Nelson, MA, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 705 Carson St, Troy, NC 27371 Phone: 910-572-4673 |
Christopher Clay Knotts, MA, LCMHC, LCAS Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 227 N Main St, Troy, NC 27371 Phone: 910-572-3681 Fax: 910-572-5579 |
Ms. Pamela Ann Roberts, LCAS-A Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 227 N Main St, Troy, NC 27371 Phone: 336-899-1571 Fax: 910-572-5579 |
Julius B. Henry Counselor Medicare: Not Enrolled in Medicare Practice Location: 227 N. Main St., Troy, NC 27371 Phone: 910-572-3681 |
Fred C. Christon Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 303 N Main St, Troy, NC 27371 Phone: 704-475-6442 |
Mrs. Heather Nicole Lewellen, LCMHCA Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 617 N Main St, Troy, NC 27371 Phone: 910-572-2225 Fax: 910-571-0234 |
Mickey Lilly Counselor Medicare: Not Enrolled in Medicare Practice Location: 227 N. Main St., Troy, NC 27371 Phone: 910-572-3681 |
Chanda Hance, LCAS-A Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 227 N Main St, Troy, NC 27371 Phone: 910-572-3681 |
Daryl David Gorden, MA, LCAS, LPC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 227 N Main St, Troy, NC 27371 Phone: 910-572-3681 Fax: 910-572-5579 |
Mr. Robert M. Nelson, MA, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 1011 Page, Troy, NC 27371 Phone: 910-576-6222 |
Michael D. Hussey Counselor Medicare: Not Enrolled in Medicare Practice Location: 227 N. Main St., Troy, NC 27371 Phone: 910-572-3681 |
Ambraya Timmons, MSW, P-LCSW Counselor Medicare: Not Enrolled in Medicare Practice Location: 318 N Main St, Troy, NC 27371 Phone: 910-576-1188 |
Judith W. Chappell, LCAS, LPCA Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 225 N Main St Ste A, Troy, NC 27371 Phone: 910-330-0033 |
Rondy Green, SAC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 227 N Main St, Troy, NC 27371 Phone: 910-572-3681 Fax: 910-572-5579 |
Melissa Ellen Bentley, LCAS Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 227 N Main St, Troy, NC 27371 Phone: 910-572-3681 Fax: 910-572-5579 |
Mr. Jonathan Wilkins, LCMHC Counselor Medicare: Not Enrolled in Medicare Practice Location: 219 N Main St, Troy, NC 27371 Phone: 919-336-7640 |
News Archive
The protein FUS, whose mutation or disruption causes many cases of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), works as a central component of one of the most important regulatory systems in cells, according to a new study in Molecular Cell from scientists at Johns Hopkins Bloomberg School of Public Health.
A new study suggests that an intervention to reduce supine sleep in late pregnancy may promote maternal and fetal health.
ACADIA Pharmaceuticals Inc., a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that it has entered into a securities purchase agreement for a private placement financing with a select group of institutional investors, including New Enterprise Associates and Venrock.
DURECT Corporation announced today that its licensee, King Pharmaceuticals, has begun a Phase IIb clinical trial to evaluate ELADURâ„¢ (TRANSDURâ„¢-Bupivacaine) for the treatment of chronic low back pain. ELADUR is an investigational transdermal drug patch intended to deliver bupivacaine for up to 3 days from a single application.
› Verified 6 days ago